Phase 2 dose-finding trial Published in The Lancet in 2021, this multicenter, randomized, double-blind trial tested cagrilintide doses ranging from 0.3 mg to 4.5 mg weekly in people with overweight or obesity
We combine them with other strategies like personalized nutrition advice, hormone balancing, and prescription medications
Immediate post-injection care focuses on minimising local reactions: Apply a cold compress to the injection site for 1015 minutes to reduce pain and swelling Avoid massaging or rubbing the area, which can increase bruising Wear loose clothing that doesn't irritate the injection site Gentle movement of the affected limb may help reduce stiffness Hydration and nutrition support general wellbeing during treatment
Instead, ASP data reporting for manufacturers of skin substitutes would become voluntary
Despite sharing a receptor with LH, emerging research has established that hCG and LH are not equivalent in their intracellular signalling profiles